Study ID: ECOG E2906
Description:
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Location:
Sioux Falls Region,Fargo Region,Bemidji Clinic
Principal Investigator:
Miroslaw Mazurczak MD,Preston Steen MD
Disease:
AML (Acute Myelogenic Leukemia)
Stage:
Phase III
Status:
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.
Back to Clinical Trials list